packageSerelaxin

serelaxin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Serelaxin, a recombinant form of human relaxin, was investigated as a treatment for heart failure. It remains investigational; a marketing application in the European Union was refused, so it is not authorised there.

Summary written by glm-5.3-flash from Wikidata Q7453086 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:serelaxin
ATC codes:C01DX21
DrugBank:DB05794
Wikidata:Q7453086
molar mass:5963 g/mol (Drugs.Common 25.09, not verified)
logP:-19.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown